Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Deutsche Bank Downgrades AstraZeneca (AZN:LN) (AZN) to Sell
February 8, 2024 5:36 AM ESTDeutsche Bank analyst Emmanuel Papadakis downgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Sell with a price target of GBP95.00 (from GBP110.00).
... MoreAstraZeneca (AZN) Tops Q4 EPS by 71c; initiates guidance
February 8, 2024 2:55 AM ESTAstraZeneca (NASDAQ: AZN) reported Q4 EPS of $1.45, $0.71 better than the analyst estimate of $0.74. Revenue for the quarter came in at $12.02 billion versus the consensus estimate of $12 billion.
GUIDANCE:
The Company issues its Total Revenue and Core EPS guidance for... More
SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain
February 7, 2024 6:53 AM ESTSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca (NASDAQ: AZN) Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health... More
